dronabinol has been researched along with levodopa in 11 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 4 (36.36) | 18.7374 |
1990's | 1 (9.09) | 18.2507 |
2000's | 4 (36.36) | 29.6817 |
2010's | 2 (18.18) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Lombardo, F; Obach, RS; Waters, NJ | 1 |
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Miczek, KA | 1 |
Bhargava, HN | 1 |
Sassin, JF | 1 |
Barkov, NK; Machula, AI | 1 |
Brotchie, JM; Fox, SH | 1 |
Brotchie, JM; Crossman, AR; Dick, JP; Fox, SH; Hill, M; Sieradzan, KA | 1 |
Brotchie, J; Crossman, A; Fox, SH; Henry, B; Hill, M | 1 |
Gilgun-Sherki, Y; Mechoulam, R; Melamed, E; Offen, D | 1 |
Dowd, E; Finn, DP; Gorman, AM; Walsh, S | 1 |
2 review(s) available for dronabinol and levodopa
Article | Year |
---|---|
Drug-induced dyskinesia in monkeys.
Topics: Amphetamine; Animals; Aromatic Amino Acid Decarboxylase Inhibitors; Azides; Carbachol; Caudate Nucleus; Chlorpromazine; Disease Models, Animal; Dronabinol; Hydroxydopamines; Levodopa; Movement Disorders; Phenothiazines; Primates; Stereotaxic Techniques; Substantia Nigra; Tegmentum Mesencephali | 1975 |
Quantitative assessment of dyskinesias in subhuman primates.
Topics: Adrenergic alpha-Antagonists; Animals; Anti-Anxiety Agents; Antiparkinson Agents; Diagnosis, Differential; Dronabinol; Dyskinesia, Drug-Induced; Haplorhini; Idazoxan; Levodopa; Primates; Severity of Illness Index | 1999 |
1 trial(s) available for dronabinol and levodopa
Article | Year |
---|---|
Cannabinoids reduce levodopa-induced dyskinesia in Parkinson's disease: a pilot study.
Topics: Aged; Animals; Cross-Over Studies; Culture Techniques; Double-Blind Method; Dronabinol; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Globus Pallidus; Humans; Levodopa; Male; Middle Aged; Parkinson Disease; Rats; Rats, Sprague-Dawley; Receptors, Cannabinoid; Receptors, Drug | 2001 |
8 other study(ies) available for dronabinol and levodopa
Article | Year |
---|---|
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
A behavioral analysis of aggressive behaviors induced and modulated by delta9-tetrahydrocannabinol, pilocarpine, d-amphetamine and l-dopa [proceedings].
Topics: Aggression; Animals; Behavior, Animal; Dextroamphetamine; Dominance-Subordination; Dronabinol; Humans; Levodopa; Pilocarpine; Rats | 1977 |
Time course of the effects of naturally occurring cannabinoids on morphine abstinence syndrome.
Topics: Amphetamine; Animals; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Humans; Levodopa; Male; Mice; Morphine Dependence; Motor Activity; Naloxone; Substance Withdrawal Syndrome | 1978 |
A study of the mediator spectrum of delta-9 tetrahydrocanabinol effects on cerebral bioelectric activity.
Topics: Animals; Apomorphine; Cats; Cerebral Cortex; Conditioning, Psychological; Dopamine; Dronabinol; Electroencephalography; Evoked Potentials, Visual; Fenclonine; Levodopa; Methyltyrosines; Methysergide; Norepinephrine; Serotonin; Somatosensory Cortex; Sympathomimetics; Visual Cortex | 1985 |
Stimulation of cannabinoid receptors reduces levodopa-induced dyskinesia in the MPTP-lesioned nonhuman primate model of Parkinson's disease.
Topics: 1-Methyl-4-phenyl-1,2,3,6-tetrahydropyridine; Animals; Antiparkinson Agents; Benserazide; Callithrix; Corpus Striatum; Dose-Response Relationship, Drug; Dronabinol; Drug Combinations; Drug Therapy, Combination; Dyskinesia, Drug-Induced; Female; gamma-Aminobutyric Acid; Globus Pallidus; Levodopa; Male; Motor Skills; Parkinsonian Disorders; Receptors, Cannabinoid; Receptors, Drug | 2002 |
The CB1 cannabinoid receptor agonist, HU-210, reduces levodopa-induced rotations in 6-hydroxydopamine-lesioned rats.
Topics: Animals; Apomorphine; Cannabinoids; Carbidopa; Cell Line, Tumor; Dronabinol; Levodopa; Male; Motor Activity; Neuroprotective Agents; Oxidopamine; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rotation; Substantia Nigra | 2003 |
The effects of cannabinoid drugs on abnormal involuntary movements in dyskinetic and non-dyskinetic 6-hydroxydopamine lesioned rats.
Topics: Animals; Antiparkinson Agents; Disease Models, Animal; Dronabinol; Dyskinesia, Drug-Induced; Levodopa; Male; Parkinsonian Disorders; Piperidines; Pyrazoles; Rats; Rats, Sprague-Dawley; Receptor, Cannabinoid, CB1; Rimonabant | 2010 |